Identify Irreversible DNA Damage to Cervical Cells – Trust the DNA
Introducing The Cervical DNA Dtex® Test

Manhattan Labs and NeoDiagnostix, Inc have proudly partnered to bring our patients and clients the Cervical DNA Dtex® Test  to help identify which HPV+ or LSIL patients are progressing to disease.

This state-of-the-art test uses fluorescent in-situ hybridization (FISH) technology to identify the irreversible DNA damage to cervical cells as defined by multiple copies of 3q26 and 5p15. Used in conjunction with Pap and HPV testing, the Cervical DNA Dtex test can assist physicians in identifying which LSIL and HPV+ patients may be at risk of progressing to severe dysplasia.

This new testing allows the clinician to optimize patient care and healthcare resources.

women dtex

You can learn more about the Cervical DNA Dtex Test from its developer, NeoDiagnostix, Inc. To learn how to schedule testing with Manhattan Labs, call us today at 800-557-6787.

All statistics regarding the Cervical DNA Dtex® Test are provided by NeoDiagnostix, Inc.

Ask Us a Question

  • Please read our Notice of Privacy Practices before sending any personal information over the internet.

  • This field is for validation purposes and should be left unchanged.